APOA1 Antikörper (AA 25-267)
Kurzübersicht für APOA1 Antikörper (AA 25-267) (ABIN950461)
Target
Alle APOA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 25-267
-
Spezifität
- The antibody recognizes human APOA1. Other species not tested.
-
Aufreinigung
- Protein-G affinity chromatography
-
Immunogen
- Recombinant human APOA1 (25-267aa) purified from E. coli
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
Andere Bezeichnung
- Apolipoprotein A I (APO AI)
-
Hintergrund
- Apolipoprotein A1 (APOA1) is the main protein component of high density lipoprotein (HDL) in plasma. This protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in APOA1 are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. High level of APOA1 is regarded as protective against atherosclerosis and cardiovascular disease.Synonyms: APOA1, Apo-AI, ApoA-I, ApoAI
-
Gen-ID
- 335
-
NCBI Accession
- NP_000030
-
UniProt
- P02647
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Target
-